View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/FDA RIN: 0910-AH69 Publication ID: Spring 2022 
Title: Updating Public Information Regulations 
Abstract:

FDA is amending its public information regulations. The amendments bring the agency’s regulations in line with statutory amendments to the FOIA, update cross references to other statutes and parts of the agency’s regulations, and clarify certain provisions with minor editorial updates. Additionally, the rule will update the current regulations to reflect changes to the organizational structure of FDA, to make the FOIA process easier for the public to navigate, and to make certain provisions clearer, such as the provisions regarding processing fees. Taken together, these changes will enhance transparency for the public with regard to FDA’s activities.

 
Agency: Department of Health and Human Services(HHS)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 20    21 CFR 720.8   
Legal Authority: 5 U.S.C. 552    18 U.S.C. 1905    19 U.S.C. 2531 to 2582    21 U.S.C. 321 to 393    21 U.S.C. 1401 to 1403    42 U.S.C. 241    42 U.S.C. 242    42 U.S.C. 242a    42 U.S.C. 242l    42 U.S.C. 242n    42 U.S.C. 243    42 U.S.C. 262    42 U.S.C. 263    42 U.S.C. 263b to 263n    42 U.S.C. 264    42 U.S.C. 265    ...   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  09/13/2018  83 FR 46437   
NPRM Comment Period End  11/13/2018 
Final Rule  07/00/2022 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Sarah Kotler
Director, Freedom of Information
Department of Health and Human Services
Food and Drug Administration
5630 Fishers Lane, Room 1035,
Rockville, MD 20857
Phone:301 796-3900
Email: sarah.kotler@fda.hhs.gov